摘要
目的:探讨消瘰丸(Ⅱ)治疗附睾炎的临床疗效。方法:61例附睾炎患者分为2组,其中急性组23例,非急性组38例。两组患者皆使用消瘰丸(Ⅱ)6 g每日2次口服,急性组患者另予抗菌药物静滴。疗程皆为4周。急性组根据临床症状和体征变化综合判断疗效,同时记录视觉疼痛评分(VAS)的改变。非急性组使用慢性附睾炎症状指数评分表(CESI)对治疗前后临床症状进行评估,并评价其疗效。结果:两组经治疗后,急性组治疗前后VAS评分从(7.08±1.09)分降到(2.10±1.37)分,差异有显著性(P<0.05)。总有效率为82.60%。非急性组治疗前后疼痛评分为(7.08±1.09)分及(2.10±1.37)分;生活质量评分为(7.28±1.14)分及(1.87±1.56)分;总分为(14.37±1.78)分及(3.97±2.73)分;差异均有显著性(P<0.05),总有效率为84.21%。结论:证实消瘰丸(Ⅱ)是临床治疗附睾炎的一种有效手段,也是现代医学的有效补充。
Objective:To observe the clinical efficacy of Xiaoluowan(II)on epididymitis.Methods:61 patients with epididymitis were divided into two groups,acute group(23 cases)and non-acute group(38 cases).Both groups of patients were treated with Xiaoluowan(II)6g twice a day orally,while acute group patients were given antibiotics intravenously.The treatment period is 4 weeks.The acute group evaluates the therapeutic efficacy comprehensively based on changes in clinical symptoms and signs,while recording changes in visual pain score(VAS).Chronic epididymitis symptom index(CESI)was used to evaluate the clinical symptoms before and after treatment in the non-acute group,and the curative efficacy was evaluated.Results:After treatment,the VAS scores in the acute group decreased from 7.08±1.09 to 2.10±1.37(P<0.05).Total efficiency is 82.60%.In the non-acute group,the scores of pain before and after treatment were 7.08±1.09 and 2.10±1.37,the scores of quality of life were 7.28±1.14 and 1.87±1.56,the total scores were 14.37±1.78 and 3.97±2.73,respectively.The difference was significant(P<0.05).Total efficiency is 84.21%.Conclusion:Xiaoluowan(II)is an effective method to treat epididymitis and an effective supplement to modern medicine.
作者
周玉春
黄卫周
商学军
ZHOU Yu-chu;HUANG Wei-zhou;SHANG Xue-jun(Department of Andrology,Affiliated Hospital of Nanjing University of Chinese Medicine,Jiangsu Province Hospital of Chinese Medicine,Jiangsu,Nanjing 210029,China;Department of Urology,General Hospital of Eastern Theater Command,Nanjing,Jiangsu 210002,China;Department of urology,Affiliated Hospital of Nanjing University of Chinese Medicine,Jiangsu Province Hospital of Chinese Medicine,Jiangsu,Nanjing 210029,China)
出处
《中华男科学杂志》
CAS
CSCD
北大核心
2023年第5期441-444,共4页
National Journal of Andrology
关键词
消瘰丸
附睾炎
临床疗效
Xiaoluowan
epididymitis
clinical effect
